Multiple sclerosis is managed through a combination of disease-modifying medications, exercise, dietary changes, mental health support, and day-to-day symptom management. No single treatment does everything, so most people with MS use several strategies together. Here’s what the evidence supports.
Disease-Modifying Therapies
Disease-modifying therapies (DMTs) are the backbone of MS treatment. They work by calming or redirecting the immune system so it causes less damage to the protective coating around nerves. There are now more than a dozen approved options, and they fall into a few broad categories based on how they work.
The earliest DMTs, sometimes called first-generation therapies, are self-injected medications that shift the immune system’s T-cells away from an inflammatory profile and toward one that causes less nerve damage. These reduce relapse rates modestly and remain widely used because of their long safety track record.
Newer oral therapies work differently. One traps immune cells inside lymph nodes so fewer of them reach the brain and spinal cord. Another slows the growth of the specific immune cells that attack nerve tissue by blocking an enzyme they need to multiply. These oral options offer convenience and, in many cases, stronger relapse reduction than the older injectables.
Infusion therapies tend to be the most potent. Some are monoclonal antibodies that physically block immune cells from crossing into the central nervous system. Others deplete large portions of the immune cell population, essentially resetting part of the immune system. These carry higher risks of serious side effects, so they’re typically reserved for aggressive or highly active disease. Your neurologist will weigh your relapse history, MRI activity, and tolerance for risk when recommending which tier of therapy makes sense.
Exercise for Mobility and Fatigue
Exercise is one of the most consistently supported interventions for MS beyond medication. Guidelines for people with mild to moderate disability recommend two to three days per week of moderate aerobic exercise and two to three days per week of resistance training.
For aerobic exercise, that means starting at about 10 minutes per session and gradually building to 30 or even 40 minutes. Moderate intensity feels like a 11 to 13 on a 20-point effort scale, roughly the point where you can hold a conversation but not sing. Walking, swimming, cycling, elliptical machines, and aquatic exercise all count. Progression should start with longer or more frequent sessions before increasing intensity.
For resistance training, aim for one to three sets of 8 to 15 repetitions across five to ten exercises targeting major muscle groups. Weight machines, free weights, and resistance bands all work. Rest two to four minutes between sets and give muscles at least a full day of recovery between sessions. As fitness improves, some people progress to five aerobic sessions per week at higher intensity, approaching 40-minute sessions.
Exercise directly helps with fatigue, which is the single most common and disabling symptom of MS. A systematic review of fatigue interventions found that exercise had supporting evidence for reducing MS-related fatigue, while no medication had strong evidence for the same. Yoga, in particular, showed strong evidence for fatigue management.
Diet and Nutrition
Three dietary patterns come up most often in MS research: the Swank diet, the Wahls protocol, and the Mediterranean diet. None has enough high-quality trial data to be officially recommended in clinical guidelines, but all three share common threads that appear beneficial.
The Swank diet, developed decades ago, caps saturated fat at 15 grams per day and limits fatty meat and processed foods. It allows fish, fruits, vegetables, and grains. The Wahls protocol is a modified paleo approach that eliminates eggs, dairy, and most grains while pushing for nine or more cups of fruits and vegetables daily, split evenly among dark leafy greens, sulfur-rich vegetables (like broccoli and onions), and deeply colored produce. A head-to-head study comparing the two found that both diets reduced fatigue and improved quality of life in people with relapsing-remitting MS, though the Wahls group saw a greater reduction in fatigue scores over 24 weeks.
The Mediterranean diet, rich in fruits, vegetables, fish, and olive oil, has been linked to reduced disability and lower fatigue scores. One small study found that people eating a Mediterranean diet had reduced levels of a key inflammatory marker after 12 months. Participants who ate less than one serving of red meat per day and consumed more fish had significantly lower fatigue.
The common denominator across all three: more vegetables, more fish, less processed food, and less saturated fat.
Vitamin D
Low vitamin D levels are consistently associated with higher MS disease activity. In a prospective study of 73 people with relapsing-remitting MS, those with blood levels above 40 ng/mL had the lowest rate of new brain lesions, while those below 20 ng/mL had significantly more relapses. For every 20 ng/mL increase in vitamin D, the growth of existing lesions dropped by about 20% per year.
Multiple studies converge on a similar target: a blood level of at least 40 ng/mL (100 nmol/L) appears to be the lower limit for controlling MRI and clinical disease activity. The Endocrine Society considers 40 to 60 ng/mL the ideal range. Most people with MS who aren’t supplementing fall well below this. A simple blood test for 25-hydroxyvitamin D can tell you where you stand, and supplementation doses vary widely depending on your starting level and body weight.
Managing Fatigue Beyond Exercise
Fatigue in MS isn’t ordinary tiredness. It can be overwhelming and disproportionate to activity level. Beyond exercise, structured energy conservation and fatigue management programs have strong evidence behind them. These programs teach you to prioritize tasks, plan rest breaks, simplify routines, and pace activities throughout the day so you don’t burn through your energy budget by noon.
On the medication side, the evidence is surprisingly thin. No drug has strong support for MS fatigue specifically. Some people get modest benefit from stimulant-type medications, but results in clinical trials have been mixed at best.
Spasticity and Muscle Stiffness
Muscle stiffness and involuntary spasms are common as MS progresses. The first-line oral treatment works by mimicking a calming brain chemical at the spinal level, reducing the signals that make muscles clench. It’s effective but can cause drowsiness and overall muscle weakness, and it needs to be tapered slowly if stopped.
A second option works by dampening the nerve signals that drive spasticity and is often combined with the first-line drug for an additive effect. It can lower blood pressure, so it’s not suitable for everyone. For people whose spasticity comes with nerve pain, an anticonvulsant medication may address both symptoms at once. A muscle-targeted option acts directly on the muscle fibers themselves, preventing them from contracting as forcefully. It doesn’t affect the brain, which means less drowsiness, but it can cause general weakness since it doesn’t distinguish between stiff muscles and healthy ones.
Stretching, physical therapy, and aquatic exercise complement medications by maintaining range of motion and preventing the joints from stiffening permanently.
Heat Sensitivity
Many people with MS experience a temporary worsening of symptoms when their body temperature rises, even by a fraction of a degree. This is called Uhthoff’s phenomenon, and it can make hot weather, exercise, hot showers, or fever feel like a relapse (though no new nerve damage is occurring).
Pre-cooling before exercise or heat exposure helps. A systematic review found that both active cooling (garments with circulating cold liquid) and passive cooling (vests with ice or gel packs) prevented symptom worsening without causing side effects. Practical strategies include wearing a cooling vest during outdoor activity, drinking cold water before and during exercise, and exercising in air-conditioned or aquatic environments.
Cognitive Rehabilitation
About half of people with MS experience some degree of cognitive change, most commonly involving processing speed, memory, and attention. Cognitive rehabilitation uses two complementary approaches: restorative training, which aims to strengthen weakened cognitive abilities through structured exercises, and compensatory strategies, which teach workarounds like using calendars, alarms, checklists, and organizational systems.
Computer-based brain training programs targeting working memory and attention have been studied in MS, and several show measurable improvements. Group-based programs that combine cognitive exercises with lifestyle strategies and self-efficacy building also show benefit. The key is consistent practice, much like physical exercise.
Depression and Anxiety
Depression affects people with MS at far higher rates than the general population, and anxiety is nearly as common. Both are driven partly by the emotional burden of living with an unpredictable chronic illness and partly by the disease process itself, since MS lesions can directly affect brain circuits involved in mood.
Cognitive behavioral therapy (CBT) has the strongest evidence base among psychological treatments for MS. Multiple trials have shown that CBT reduces depression, lowers anxiety, improves coping, and builds self-efficacy. It works both in individual and group formats. One trial found that group CBT led to lower anxiety and better psychological resilience compared to an information-only control group. Two smaller trials focused specifically on people with MS and depression both showed significant improvements in mood with CBT.
Treating Acute Relapses
When a relapse hits, with new or worsening neurological symptoms lasting more than 24 hours, the standard treatment is a short course of high-dose corticosteroids. The typical regimen is 500 mg to 1 gram taken orally once daily for three to five consecutive days. This can also be given intravenously in a clinic or hospital if the oral version isn’t tolerated or the relapse is severe. Corticosteroids shorten the duration and severity of the relapse but don’t change the long-term course. Evidence suggests that a gradual taper afterward doesn’t offer additional benefit for most people.
If corticosteroids don’t provide adequate relief, plasma exchange (a procedure that filters inflammatory proteins from the blood) is sometimes used as a second-line option for severe relapses.